EDIT vs RIVN · rev $32.3M vs rev $5.39B
Editas Medicine Inc (EDIT) versus Rivian Automotive Inc (RIVN) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Rivian Automotive Inc (RIVN) is a auto manufacturers company listed on NASDAQ. It is led by RJ Scaringe.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported RIVN revenue for 2025-12-31 was $5.39B. Net income was -$3.65B. Revenue was up 8.4% from 2024-12-31 to 2025-12-31. RIVN currently screens at market cap $21.81B.
EDIT currently screens at market cap $375.2M. RIVN currently screens at market cap $21.81B.
Not investment advice. Open the EDIT and RIVN stock pages for the full models.
Not investment advice.